Brand names: Technescan Pyp
Route: Intravenous
Contraindications
CONTRAINDICATIONS None known.
Pregnancy & Breastfeeding
Pregnancy Animal reproduction studies have not been conducted with Technetium Tc 99m Pyrophosphate Injection. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. All radiopharmaceuticals, including Technescan PYP, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. If considering Technescan PYP administration to a pregnant woman, inform the patient about the potential for adverse pregnancy outcomes based on the radiation dose from technetium Tc 99m pyrophosphate and the gestational timing of exposure.
3 interactions on record
High levels of aluminum from concomitant medications may alter biodistribution of technetium Tc 99m pyrophosphate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.
Source: NLP:technetium tc 99m pyrophosphate
High levels of calcium from concomitant medications may alter biodistribution of technetium Tc 99m pyrophosphate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.
Source: NLP:technetium tc 99m pyrophosphate
High levels of iron from concomitant iron infusions may alter biodistribution of technetium Tc 99m pyrophosphate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.
Source: NLP:technetium tc 99m pyrophosphate